Core Viewpoint - The company is focusing on the research and development of innovative traditional Chinese medicine, particularly the Wuling series products [1] Group 1 - The company is actively implementing a strategic layout of "initiating a batch, conducting clinical trials for a batch, and launching a batch" [1] - Currently, the company has innovative drugs under research, including Lingxiang tablets, which are undergoing Phase II clinical trials [1] - There are three other innovative traditional Chinese medicines from the Wuling series that are in preclinical toxicology and pharmaceutical research [1]